Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-4-13
pubmed:abstractText
Sequential use of antiarrhythmic drugs may improve prognosis in chronic atrial fibrillation (AF). We conducted a prospective study of the efficacy of sequential antiarrhythmic drug therapy in sinus rhythm (SR) maintenance after a successful electrocardioversion (CV) in pts with chronic AF.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1234-1010
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11208496-Aged, pubmed-meshheading:11208496-Amiodarone, pubmed-meshheading:11208496-Anti-Arrhythmia Agents, pubmed-meshheading:11208496-Atrial Fibrillation, pubmed-meshheading:11208496-Chronic Disease, pubmed-meshheading:11208496-Disopyramide, pubmed-meshheading:11208496-Echocardiography, pubmed-meshheading:11208496-Electric Countershock, pubmed-meshheading:11208496-Electrocardiography, pubmed-meshheading:11208496-Follow-Up Studies, pubmed-meshheading:11208496-Heart Rate, pubmed-meshheading:11208496-Humans, pubmed-meshheading:11208496-Middle Aged, pubmed-meshheading:11208496-Patient Selection, pubmed-meshheading:11208496-Prognosis, pubmed-meshheading:11208496-Propafenone, pubmed-meshheading:11208496-Sotalol, pubmed-meshheading:11208496-Time Factors, pubmed-meshheading:11208496-Treatment Failure, pubmed-meshheading:11208496-Treatment Outcome
pubmed:articleTitle
Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
pubmed:affiliation
Department of Internal Diseases and Cardiology, 1st Faculty of Medicine, Medical University in Warsaw, ul. Banacha 1a, 02-097 Warsaw, Poland.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study